好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2021 Annual Meeting | Neuro-oncology Posters

This program spans the entire conference
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Neuro-oncology
0.00 credit
COVID-19

Program Materials Program Evaluations

Event Timeline
07:00 AM - 05:00 PM EDT Abstract 001 - Synchronous Diagnosis of Multicentric Glioma with Distinct Molecular Profiles
Kristen A. Batich, PhD
07:00 AM - 05:00 PM EDT Abstract 002 - Implications of TIGAR Within Glioblastoma Multiforme Drug Resistance
Joseph Sahagun
07:00 AM - 05:00 PM EDT Abstract 003 - Glioblastoma Clinical Trials for Urban and Rural Patients in the United States from 2010-2020
Kathryn S. Nevel, MD
07:00 AM - 05:00 PM EDT Abstract 004 - A Retrospective Cohort Study of Medical Cannabis Treatment in Patients with Glioblastoma Multiforme
Vincent H. Bargnes III
07:00 AM - 05:00 PM EDT Abstract 005 - Primary Brain Tumor Patients Experience Significant Sleep Disturbance; An Analysis of Clinical Characteristics and Sleep Parameters
Zaid A. Soomro, MBBS
07:00 AM - 05:00 PM EDT Abstract 006 - Effects of Corticosteroids on Metabolic Syndrome in Glioblastoma
Varun Mehta, MD
07:00 AM - 05:00 PM EDT Abstract 007 - Use of medical assistance in dying (“Death with Dignity”) in Washington state patients with brain tumors.
Jerome J. Graber, MD, MPH, FAAN
07:00 AM - 05:00 PM EDT Abstract 008 - Defining Personal and Communal Aspects of Social Determinants of Health in Glioma Population
Alexandria Marshall
07:00 AM - 05:00 PM EDT Abstract 009 - Awareness and Agreement with Neurofibromatosis Care Expert Recommendations among Neurofibromatosis Specialists
Justin T. Jordan, MD, MPH, FAAN
07:00 AM - 05:00 PM EDT Abstract 010 - Assessing the Utility and Attitudes Towards Molecular Testing in Neuro-Oncology: A Survey of the Society of Neuro-Oncology Members
Shannon Fortin Ensign, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 011 - Incidence, risk factors and management of venous thromboembolisms in patients with primary CNS lymphoma
Miyabi Saito
07:00 AM - 05:00 PM EDT Abstract 012 - Patient-centered Outcome Measures as a Means of Measuring the Effect of Tumor-related Epilepsy on Quality of Life in Patients with High-grade Glioma
Thomas Wychowski, MD
07:00 AM - 05:00 PM EDT Abstract 013 - Catastrophic Events Related to Tuberous Sclerosis Complex (TSC) Are Unlikely In a Heterogeneous Adult Cohort of TSC Patients
Lauren A. Neal
07:00 AM - 05:00 PM EDT Abstract 014 - Neurological Manifestations In Adults With Neurofibromatosis Type I
Hans H. Shuhaiber, MD
07:00 AM - 05:00 PM EDT Abstract 015 - Assessment of Survival and Safety Following Intrathecal Chemotherapy via Ommaya Reservoir for Leptomeningeal Disease
07:00 AM - 05:00 PM EDT Abstract 016 - CCM Signaling Complex is a Master Regulator Governing Homeostasis of Progesterone, Coupled with Disrupted Blood-Brain Barrier Integrity
Rui T. Tang, MD
07:00 AM - 05:00 PM EDT Abstract 017 - Safety and Feasibility of Intrathecal Pembrolizumab Infusion in Refractory Triple Negative Breast Cancer with Leptomeningeal Disease
Shannon Fortin Ensign, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 018 - A Case of Isolated Leptomeningeal Progression in a Patient with NTRK Fusion + Uterine Sarcoma
Tyler Lanman, MD
07:00 AM - 05:00 PM EDT Abstract 019 - Migratory Focal Neurological Deficits due to Non-Ischemic Leukoencephalopathy: A Methotrickster of Stroke Mimics
Tu Nguyen, MD
07:00 AM - 05:00 PM EDT Abstract 020 - Transverse Myelitis as a Presenting Sign of Intravascular Lymphoma: A Report of Two Cases
Sam Hooshmand, DO
07:00 AM - 05:00 PM EDT Abstract 021 - A Rare Case of Co-occurrence of Astrocytoma and Oligodendroglioma
Keerthana Nalamada, MBBS
07:00 AM - 05:00 PM EDT Abstract 022 - Diagnosing the Newly Defined CNS Myxoid Glioneuronal Tumor: A Pediatric Case Report
Mackenzie Silverman, MD
07:00 AM - 05:00 PM EDT Abstract 023 - Clinical Response to Pazopanib in a Patient with Endolymphatic Sac Tumor Not Associated with von Hippel-Lindau Syndrome
Thomas A. Nelson, MD
07:00 AM - 05:00 PM EDT Abstract 024 - Polyradiculoplexopathy as an Initial Manifestation of CNS Lymphoma: A Case Report
Carolyn Foster Aldendail, MD
07:00 AM - 05:00 PM EDT Abstract 025 - A Case of Late Onset Encephalitis Secondary to Nivolumab
Shrikant Mishra, MD
07:00 AM - 05:00 PM EDT Abstract 026 - Stroke-Like Migraine Attacks After Radiation Therapy (SMART) Syndrome: A Case Series
Sebastian Friedrich Winter
07:00 AM - 05:00 PM EDT Abstract 027 - Profound CNS Multiple Myeloma Carcinomatosis Causing Weakness and Vision Loss
William Hoffman, MD
07:00 AM - 05:00 PM EDT Abstract 028 - Intrasvascular B-cell lymphoma presenting as Cortical Venous Thrombosis
Praveen Hariharan, MD
07:00 AM - 05:00 PM EDT Abstract 029 - Incidental Chiasmal Rosette-Forming Glioneuronal Tumour at Post-Mortem
Georgia Richard, MB BCh BAO
07:00 AM - 05:00 PM EDT Abstract 030 - Acute Lymphoblastic Leukemia (ALL) masquerading as Guillain Barre Syndrome (GBS)
Mustafa Al-Chalabi, DO
07:00 AM - 05:00 PM EDT Abstract 031 - Primary Leptomeningeal Medulloblastoma: A Rare Presentation of a Rare Disease
Venus Barlas
07:00 AM - 05:00 PM EDT Abstract 032 - Asymptomatic irAEs: CLIPPERS-like Lesions and Pachymeningeal Enhancement following Anti-PD-1 Inhibitors
Carlen A. Yuen, MD
07:00 AM - 05:00 PM EDT Abstract 033 - Miliary Brain Metastases: A Radiologic-pathologic Definition
Geraldine Faivre, MD
07:00 AM - 05:00 PM EDT Abstract 034 - A Rare Etiology for Stroke like Symptoms: SMART syndrome with uncommon Imaging Findings
Jessie Jacobson, DO
07:00 AM - 05:00 PM EDT Abstract 035 - A Case Report of Paraneoplastic Spastic Paraparesis in a Young Female with Nodular Sclerosing Lymphoma
Zachary J. Craig, MD
07:00 AM - 05:00 PM EDT Abstract 036 - The Diagnostic Odyssey of Anterior Chiasmal Cavernous Hemangioma
Maya Hrachova, DO
07:00 AM - 05:00 PM EDT Abstract 037 - Primary Skull Base Lymphoma: A Case Report of a Rare and Diagnostically Challenging Etiology of Multiple Cranial Neuropathies
Ahmed Abbas, MD
07:00 AM - 05:00 PM EDT Abstract 038 - High Grade Glioma of the Spinal Cord: A Cases Series of Rare Malignancy
Madison Shoaf, MD
07:00 AM - 05:00 PM EDT Abstract 039 - Atypical Neoplastic Infiltration in the Cerebellum with Imaging and Clinical Findings Mimicking Cerebellitis
Raymond M. Rivera Vergara, MD
07:00 AM - 05:00 PM EDT Abstract 040 - Acute Cerebellitis in an Adult Patient with Uterine Carcinosarcoma after receiving Cytotoxic Chemotherapy
Osama M. Abu-hadid, MD
07:00 AM - 05:00 PM EDT Abstract 041 - CSF and MRI negative diffuse leptomeningeal carcinomatosis presenting with episodic tinnitus, anisocoria, and drop attacks
Joshua A. Budhu, MD
07:00 AM - 05:00 PM EDT Abstract 042 - An Unusual Presentation of Radiation Necrosis in the Brainstem
Alexander C. Ou, MD
07:00 AM - 05:00 PM EDT Abstract 043 - Rare Case of Primary Dural Based Marginal Zone B-Cell Lymphoma Camouflaging as Mild Focal Dura Thickness and Pachymeningeal Enhancement
Maya Hrachova, DO
07:00 AM - 05:00 PM EDT Abstract 044 - Meningioma with leptomeningeal dissemination
Orwa Aboud, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 045 - Diagnostic Delay due to COVID-19 Pandemic - A Case of Primary CNS Lymphoma
Ugur Sener, MD
07:00 AM - 05:00 PM EDT Abstract 046 - A Case of Asymmetric Weakness with Voice Changes and Hearing Loss: T-Cell ALL-associated Paraneoplastic Syndrome
Cameron Mohammadi, MD
Faculty Disclosures
Johnny A. Sanabria Lopez, MD Dr. Sanabria Lopez has nothing to disclose.
Seema Nagpal, MD, FAAN Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mirati. Dr. Nagpal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiyatec. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Telix. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Midatech.
No disclosure on file
Shannon Fortin Ensign, MD, PhD Dr. Fortin Ensign has nothing to disclose.
Jennifer N. Serventi, PA Ms. Serventi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure.
Tanvi Nadkarni, MD Dr. Nadkarni has nothing to disclose.
Varun Mehta, MD Varun Mehta has nothing to disclose.
Jonathan R. Isaacson, MD Dr. Isaacson has nothing to disclose.
Katrina Badiola, MD Dr. Badiola has nothing to disclose.
Mustafa Al-Chalabi, DO Dr. Al-Chalabi has nothing to disclose.
Gretchen L. Birbeck, MD, MPH, DTMH, FAAN An immediate family member of Dr. Birbeck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Birbeck has a non-compensated relationship as a Ambassador for Zambia with RSTMH that is relevant to AAN interests or activities.
Zachary J. Craig, MD Dr. Craig has nothing to disclose.
Alexander C. Ou, MD Dr. Ou has nothing to disclose.
Vincent H. Bargnes III Mr. Bargnes has received research support from Harry Dent Family Foundation.
Franchesca Fiorito Torres, MD Dr. Fiorito Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. Dr. Fiorito Torres has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Fiorito Torres has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli-Lilly. Dr. Fiorito Torres has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biohaven. Dr. Fiorito Torres has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie/Allergan. Dr. Fiorito Torres has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Fiorito Torres has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis.
Zaid A. Soomro, MBBS Dr. Soomro has nothing to disclose.
Noor A. Pirzada, MD, FAAN Dr. Pirzada has nothing to disclose.
Miyabi Saito Miyabi Saito has nothing to disclose.
Rui T. Tang, MD Mr. Tang has nothing to disclose.
GURCHARANJEET KAUR, MBBS Dr. Kaur has nothing to disclose.
Bernard Bendok, MD No disclosure on file
Abdullah M. Alam, MD Mr. Alam has nothing to disclose.
Ahmed Z. Obeidat, MD, PhD Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genentech. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon pharmaceuticals . Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sandoz. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for EMD Serono. Dr. Obeidat has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner life sciences . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/genzyme. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Horizon therapeutics . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. The institution of Dr. Obeidat has received research support from NIH. The institution of Dr. Obeidat has received research support from NMSS and PCORI. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Expert opinion and key opinion leader with MJH life sciences . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Faculty Speaker with CMSC. Dr. Obeidat has a non-compensated relationship as a Board member with CMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Editorial Board Member with IJMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Reviewer Editor with Frontiers Neurology that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Board of Trustee Member with National MS Society that is relevant to AAN interests or activities.
John P. Lovell, DO Dr. Lovell has nothing to disclose.
Ugur Sener, MD Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier Pharmaceuticals. Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Nicole Ullrich, MD, PhD, MMSci, FAAN Dr. Ullrich has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. The institution of Dr. Ullrich has received research support from Children's Tumor Foundation. Dr. Ullrich has received intellectual property interests from a discovery or technology relating to health care. Dr. Ullrich has received publishing royalties from a publication relating to health care.
Kristina J. Lopez, MD Dr. Lopez has nothing to disclose.
Maya Hrachova, DO Dr. Hrachova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SpringWorks Therapeutics.
Joshua P. Klein, MD, PhD, FANA, FAAN Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw-Hill. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oakstone Publishers. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer. Dr. Klein has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for various law firms. Dr. Klein has received publishing royalties from a publication relating to health care.
John H. Sladky, MD, FAAN Dr. Sladky has nothing to disclose.
Lynne P. Taylor, MD, FAAN Dr. Taylor has received publishing royalties from a publication relating to health care.
Bhavesh Trikamji, MD Dr. Trikamji has nothing to disclose.
Anthony Reder, MD The institution of Dr. Reder has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for genentech. Dr. Reder has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for serono. Dr. Reder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for sanofi. The institution of Dr. Reder has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for bms. Dr. Reder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NK max. Dr. Reder has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genentech. Dr. Reder has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for medlink. The institution of Dr. Reder has received research support from genentech. The institution of Dr. Reder has received research support from biogen. The institution of Dr. Reder has received research support from serono. The institution of Dr. Reder has received research support from novartis.
Jeremy Rudnick, MD Dr. Rudnick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure.
David Schiff, MD, FAAN Dr. Schiff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Pharmaceutical. Dr. Schiff has received publishing royalties from a publication relating to health care.
Nathan Lightfoot, DO Dr. Lightfoot has nothing to disclose.
Scott R. Plotkin, MD, PhD, FAAN Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NFlection Therapeutics. Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Akouos. Dr. Plotkin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SonALAsense. Dr. Plotkin has stock in NFlection Therapeutics. Dr. Plotkin has stock in NF2 Therapeutics. Dr. Plotkin has stock in SonALAsense. Dr. Plotkin has received research support from Children's Tumor Foundation. Dr. Plotkin has received research support from Department of Defense. Dr. Plotkin has received research support from National Institutes of Health. Dr. Plotkin has received intellectual property interests from a discovery or technology relating to health care.
Adam J. Meisler Mr. Meisler has nothing to disclose.
Thomas A. Nelson, MD Dr. Nelson has nothing to disclose.
Fang-Chi Hsu No disclosure on file
Xiao-Tang Kong, MD, PhD Dr. Kong has nothing to disclose.
Orwa Aboud, MD, PhD Dr. Aboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier.
Orin Bloch Orin Bloch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Monteris Medical. Orin Bloch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BrainLab. The institution of Orin Bloch has received research support from NIH.
Mackenzie Silverman, MD Mr. Silverman has nothing to disclose.
Thomas Wychowski, MD Dr. Wychowski has nothing to disclose.
Chelsea Shugars, MD Dr. Shugars has nothing to disclose.
Jessica Abreu Garcia, MD Dr. Abreu Garcia has nothing to disclose.
Han Lee An immediate family member of Han Lee has stock in Gilead.
Narges Moghimi, MD Dr. Moghimi has nothing to disclose.
Kristen A. Batich, PhD Kristen Batich has nothing to disclose.
Mohammad H. El-Ghanem, MD Dr. El-Ghanem has nothing to disclose.
Kathryn S. Nevel, MD Dr. Nevel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier Pharmaceuticals. Dr. Nevel has received publishing royalties from a publication relating to health care. Dr. Nevel has received personal compensation in the range of $500-$4,999 for serving as a Interviewer with Continuum Audio.
Glenn Lesser No disclosure on file
Anna Kafka, DO Dr. Kafka has nothing to disclose.
Tyler Lanman, MD Dr. Lanman has nothing to disclose.
Irfan S. Sheikh, MD Dr. Sheikh has nothing to disclose.
Katherine B. Peters, MD, PhD, FAAN Dr. Peters has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sapience. Dr. Peters has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NuVox Therapeutics. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO Pharmaceutical. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AnHeart. Dr. Peters has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Rigel. The institution of Dr. Peters has received research support from Biomimetix. The institution of Dr. Peters has received research support from Servier. The institution of Dr. Peters has received research support from Varian. The institution of Dr. Peters has received research support from Sapience. The institution of Dr. Peters has received research support from Ono Pharmaceuticals.
Sebastian Friedrich Winter Mr. Winter has nothing to disclose.
Nimish A. Mohile, MD, FAAN The institution of Dr. Mohile has received research support from Novocure.
Lauren A. Neal Miss Neal has nothing to disclose.
Venus Barlas Venus Barlas has nothing to disclose.
Joy E. Burke, MD No disclosure on file
Alexandria Marshall Ms. Marshall has nothing to disclose.
Kaleb H. Yohay, MD Dr. Yohay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Yohay has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Yohay has received publishing royalties from a publication relating to health care.
Ammar Tarabichi, MD Dr. Tarabichi has nothing to disclose.
Jethro Hu, MD Dr. Hu has nothing to disclose.
Ahmed Abbas, MD Dr. Abbas has nothing to disclose.
Matthew McCracken Mr. McCracken has nothing to disclose.
John F. De Groot, MD An immediate family member of Dr. De Groot has received personal compensation for serving as an employee of Ziopharm Oncology. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Celldex. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Deciphera Pharmaceuticals. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for FivePrime Therapeutics, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GW Pharma. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Carthera. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kadmon. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Biomedical Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Taiho Pharmaceuticals. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kairos Venture Investments. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Syneos Health. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Monteris. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Agios. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mundipharma Research. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GenomiCare. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Blue Earth Diagnostics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Del Mar Pharmaceuticals. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Insightec. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Voyager Therapeutics, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck & Co.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tocagen. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bioasis Technologies, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ResTORbio, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celldex. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Foundation Medicine, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novogen. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Deciphera. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Insys Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck & Co.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lily. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novella Clinical. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Karyopharm Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Blue Earth Diagnostics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kiyatec. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vanquish Oncology. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orsenix, Insightec. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prelude Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Debiopharm Therapeutics, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Global Services, LLC. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VBL Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novella. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VBI Vaccines, Inc.. An immediate family member of Dr. De Groot has received stock or an ownership interest from Ziopharm Oncology. An immediate family member of Dr. De Groot has received stock or an ownership interest from Gilead. The institution of Dr. De Groot has received research support from Carthera. The institution of Dr. De Groot has received research support from HaiHe Pharma. The institution of Dr. De Groot has received research support from Taiho Pharma.
Madison Shoaf, MD Dr. Shoaf has nothing to disclose.
Tu Nguyen, MD Dr. Nguyen has nothing to disclose.
Daniel M. Reyes De Jesus, MD Dr. Reyes De Jesus has nothing to disclose.
Geraldine Faivre, MD Dr. Faivre has nothing to disclose.
Sudhakar Tummala, MD, FAAN Dr. Tummala has nothing to disclose.
Maciej M. Mrugala, MD, PhD, MPH, FAAN Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Veevo Biomedicines Inc. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arbor Pharmaceuticals. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra-Zeneca. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyiatec . The institution of Dr. Mrugala has received research support from Arbor Pharmaceuticals. Dr. Mrugala has a non-compensated relationship as a Program Director with Society for Neuro-Oncology that is relevant to AAN interests or activities.
Geoffrey Ahern, MD, PhD Dr. Ahern has nothing to disclose.
Kourosh Rezania, MD, FAAN Dr. Rezania has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Akcea. Dr. Rezania has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam.
Staley A. Brod, MD Dr. Brod has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Brod has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi.
Georgia Richard, MB BCh BAO Dr. Richard has nothing to disclose.
Kelly E. Knolton, DO Dr. Knolton has nothing to disclose.
Lisa M. Arnold, DO Dr. Arnold has nothing to disclose.
Jorg Dietrich, MD, PhD, FAAN Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Dietrich has received publishing royalties from a publication relating to health care.
Jessie Jacobson, DO Dr. Jacobson has nothing to disclose.
Shaweta Khosa Ms. Khosa has nothing to disclose.
Carlen A. Yuen, MD Dr. Yuen has nothing to disclose.
Faraze Niazi Ms. Niazi has nothing to disclose.
Jason N. Harris, MD The institution of Dr. Harris has received research support from DOD. The institution of Dr. Harris has received research support from DOD.
Keerthana Nalamada, MBBS Dr. Nalamada has received personal compensation in the range of $50,000-$99,999 for serving as a Movement Disorder Fellow with Parkinson's Foundation.
Samuel D. Capouch, MD Dr. Capouch has nothing to disclose.
David Blas-Boria, MD, FAAN Dr. Blas-Boria has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure.
Robert A. Joshua, MD Dr. Joshua has nothing to disclose.
Jane Boggs, MD The institution of Dr. Boggs has received research support from Liva Nova. Dr. Boggs has a non-compensated relationship as a Chairman PAB with Epilepsy Alliance North Carolina that is relevant to AAN interests or activities.
Alissa A. Thomas, MD, FAAN The institution of Dr. Thomas has received research support from Novocure. The institution of Dr. Thomas has received research support from Ono Pharmaceuticals.
Osama M. Abu-hadid, MD Dr. Abu-hadid has nothing to disclose.
Sam Hooshmand, DO Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech/Roche. Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi . Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Hooshmand has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Hooshmand has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics .
Joshua A. Budhu, MD Dr. Budhu has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Budhu has received research support from BMSF. The institution of Dr. Budhu has received research support from Commonwealth Fund. The institution of Dr. Budhu has received research support from National Cancer Institute . The institution of Dr. Budhu has received research support from Memorial Sloan Kettering Cancer Center. The institution of Dr. Budhu has received research support from United Hospital Fund. Dr. Budhu has received personal compensation in the range of $500-$4,999 for serving as a Peer Reviewer with Medscape.
Vanessa Merker The institution of Vanessa Merker has received research support from Children's Tumor Foundation . The institution of Vanessa Merker has received research support from NF Northeast. The institution of Vanessa Merker has received research support from Patient Centered Outcomes Research Institute. The institution of Vanessa Merker has received research support from U.S. Department of Defense . The institution of Vanessa Merker has received research support from Neurofibromatosis Therapeutic Accleration Project. Vanessa Merker has received personal compensation in the range of $10,000-$49,999 for serving as a Science Writer with Neurofibromatosis Network.
Micah Etter, MD Dr. Etter has nothing to disclose.
Hamza Coban, MD Dr. Coban has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono.
Gauri V. Pawar, MD, FAAN Dr. Pawar has nothing to disclose.
Melanie D. Ward, MD Dr. Ward has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Ward has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. Ward has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ward has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Ward has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. The institution of Dr. Ward has received research support from Genentech.
Richard Butterfield No disclosure on file
Raymond M. Rivera Vergara, MD Dr. Rivera Vergara has nothing to disclose.
Faisal A. Ibrahim, MD Dr. Ibrahim has nothing to disclose.
Carolyn Foster Aldendail, MD Dr. Foster Aldendail has nothing to disclose.
Taehong Lim, MD Dr. Lim has nothing to disclose.
Anum H. Riaz, MD Dr. Riaz has nothing to disclose.
Melissa A. Morales Garcia, MD Dr. Morales Garcia has nothing to disclose.
Matthew C. Miles Matthew C Miles has nothing to disclose.
Jason S. Hawley, MD Dr. Hawley has nothing to disclose.
Nasar Ali, DO Dr. Ali has nothing to disclose.
Praveen Hariharan, MD Dr. Hariharan has nothing to disclose.
Karylane Palermo-Cruz, MD Dr. Palermo-Cruz has nothing to disclose.
Conor Fearon, MD Dr. Fearon has nothing to disclose.
Hans H. Shuhaiber, MD The institution of Dr. Shuhaiber has received research support from SPRINGWORKS . The institution of Dr. Shuhaiber has received research support from RECURSION . The institution of Dr. Shuhaiber has received research support from AstraZeneca. The institution of Dr. Shuhaiber has received research support from CTF. The institution of Dr. Shuhaiber has received research support from NFLECTION .
Shakti Nayar, MD Dr. Nayar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Nayar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Nayar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. Dr. Nayar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Cameron Mohammadi, MD Dr. Mohammadi has nothing to disclose.
Fatima C. Khalid, MD Dr. Khalid has nothing to disclose.
Ruben Fragoso Ruben Fragoso has nothing to disclose.
Ahmad Daher, MD, PhD Dr. Daher has nothing to disclose.
Roy E. Strowd III, MD, FAAN Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks . Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Machteld E. Hillen, MD, FAAN The institution of Dr. Hillen has received research support from Genentech.
Shrikant Mishra, MD Dr. Mishra has nothing to disclose.
Jillian M. Berkman, MD Dr. Berkman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medzown. Dr. Berkman has stock in Medzown.
Andrea C. Wasilewski, MD Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier Pharmaceuticals .
Imaad Nasir, MD Dr. Nasir has nothing to disclose.
William C. Hoffman No disclosure on file
Laszlo Mechtler, MD, FEAN, FASN, FAHS, FAAN Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharma. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Genomate Health. The institution of Dr. Mechtler has received research support from The Harry Dent Family Foundation, Inc. The institution of Dr. Mechtler has received research support from Alpheus medical. The institution of Dr. Mechtler has received research support from Shiratronics. The institution of Dr. Mechtler has received research support from Abbvie Inc. The institution of Dr. Mechtler has received research support from Amgen. The institution of Dr. Mechtler has received research support from Eli Lilly Company. The institution of Dr. Mechtler has received research support from H. Lundbeck HS. The institution of Dr. Mechtler has received research support from Pfizer. Dr. Mechtler has received personal compensation in the range of $100,000-$499,999 for serving as a Ownership interest with Neurology Practce Consortium GPO. Dr. Mechtler has a non-compensated relationship as a Board member with International Headache Society that is relevant to AAN interests or activities.
Marco A. Gonzalez, MD, FAAN Dr. Gonzalez Castellon has nothing to disclose.
Jerome J. Graber, MD, MPH, FAAN Dr. Graber has received personal compensation for serving as an employee of Binaytara Foundation. Dr. Graber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 好色先生. Dr. Graber has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dickie McCamey Attorneys at Law. Dr. Graber has a non-compensated relationship as a Editorial Board member with Neuro-Oncology: Practice, published by Oxford that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Journal of Pain and Symptom Management that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Board of Directors with American Society of Neuroimaging that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Board of Directors and Certification Exam Committee Member with United Council of Neurological Subspecialties that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Question of the Day 'app' committee and NeuroSAE and Continuum with 好色先生 that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Practical Neurology (BMC) that is relevant to AAN interests or activities.
Joseph Sahagun Mr. Sahagun has nothing to disclose.
Peggy Auinger Ms. Auinger has nothing to disclose.
Theodore Stem No disclosure on file
Justin T. Jordan, MD, MPH, FAAN Dr. Jordan has received personal compensation for serving as an employee of City of Beverly. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Dietitians on Demand. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Genesis HR Solutions. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Navio Theragnostics. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Recursion Pharmaceuticals, Inc. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shepherd Therapeutics. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akeila Bio. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Springworks Therapeutics. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Pharmaceuticals. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Continental Casualty Company. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for HennLesperance. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Rhoades McKee. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wheeler Trigg O'Donnell. Dr. Jordan has stock in Navio Theragnostics. Dr. Jordan has stock in The Doctor Lounge. An immediate family member of Dr. Jordan has stock in OldGate. Dr. Jordan has stock in Akeila Bio. Dr. Jordan has stock in Shepherd Therapeutics. Dr. Jordan has stock in Khora TX. The institution of Dr. Jordan has received research support from NIH. The institution of Dr. Jordan has received research support from Department of Defense. The institution of Dr. Jordan has received research support from PCORI. Dr. Jordan has received publishing royalties from a publication relating to health care. Dr. Jordan has a non-compensated relationship as a board member with United Council for Neurologic Subspecialties that is relevant to AAN interests or activities.
Paul B. Hart Mr. Hart has nothing to disclose.
William Hoffman, MD The institution of Dr. Hoffman has received research support from United States Air Force. Dr. Hoffman has a non-compensated relationship as a Member with United States Air Force that is relevant to AAN interests or activities.